s and attempts in some children. Many advocates of the stronger warnings feel that this was long overdue and the FDA should have acted several years ago when the debate over the anti depressant medication first arose.

A recent report from Reuters talks about the recent upheaval of angry and grieving family members petitioning the FDA for new strong warnings on anti depressant drugs, arguing that the increased risk of suicidal behavior seen in children also applies to adults.

Many psychiatrists oppose these new warnings afraid that the stronger warnings could scare away potential users from effectively treating their depression. Depression if gone untreated, could lead to suicide.

The Reuters report states, “A Food and Drug Administration analysis found short-term therapy with the newest antidepressants seemed to increase the chances of suicidal thoughts and actions in adults up to age 25. The drugs appeared to reduce suicidal behavior in older adults, particularly after age 65.”

The FDA is considering adding an additional warning to the drug that says it may trigger suicidal thoughts and attempts in some children. Many advocates of the stronger warnings feel that this was long overdue and the FDA should have acted several years ago when the debate over the anti depressant medication first arose.

R

in children also applies to adults.

Many psychiatrists oppose these new warnings afraid that the stronger warnings could scare away potential users from effectively treating their depression. Depression if gone untreated, could lead to suicide.

The Reuters report states, “A Food and Drug Administration analysis found short-term therapy with the newest antidepressants seemed to increase the chances of suicidal thoughts and actions in adults up to age 25. The drugs appeared to reduce suicidal behavior in older adults, particularly after age 65.”

The FDA is considering adding an additional warning to the drug that says it may trigger suicidal thoughts and attempts in some children. Many advocates of the stronger warnings feel that this was long overdue and the FDA should have acted several years ago when the debate over the anti depressant medication first arose.

ted, could lead to suicide.

The Reuters report states, “A Food and Drug Administration analysis found short-term therapy with the newest antidepressants seemed to increase the chances of suicidal thoughts and actions in adults up to age 25. The drugs appeared to reduce suicidal behavior in older adults, particularly after age 65.”

The FDA is considering adding an additional warning to the drug that says it may trigger suicidal thoughts and attempts in some children. Many advocates of the stronger warnings feel that this was long overdue and the FDA should have acted several years ago when the debate over the anti depressant medication first arose.

adults up to age 25. The drugs appeared to reduce suicidal behavior in older adults, particularly after age 65.”

The FDA is considering adding an additional warning to the drug that says it may trigger suicidal thoughts and attempts in some children. Many advocates of the stronger warnings feel that this was long overdue and the FDA should have acted several years ago when the debate over the anti depressant medication first arose.

s and attempts in some children. Many advocates of the stronger warnings feel that this was long overdue and the FDA should have acted several years ago when the debate over the anti depressant medication first arose.

Reuters reported: Suzanne Gonzalez testified that her 40-year-old husband shot himself in the head shortly after he started taking GlaxoSmithKline Plc's Paxil.

"I hold you all responsible for his death, and I always will," Gonzalez shouted to FDA officials and outside experts seated around tables in a hotel meeting room.

"I keep asking myself ... what was my husband thinking? How crazy did you make him that morning that he would get up .. and do this to himself?" she said.

For more related articles visit our blog: Foreign Pharmacy Tips.